Danielle Antalffy
Stock Analyst at UBS
(3.82)
# 711
Out of 5,081 analysts
190
Total ratings
51.82%
Success rate
8.76%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Neutral | $95 → $102 | $101.97 | +0.03% | 12 | Nov 19, 2025 | |
| PODD Insulet | Upgrades: Buy | $355 → $400 | $307.56 | +30.06% | 13 | Nov 19, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $6.5 → $5.85 | $2.68 | +118.28% | 8 | Nov 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $96 → $88 | $93.10 | -5.48% | 6 | Nov 6, 2025 | |
| INMD InMode | Maintains: Neutral | $16 → $16 | $14.44 | +10.80% | 5 | Nov 6, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 → $95 | $64.85 | +46.49% | 10 | Nov 3, 2025 | |
| BAX Baxter International | Maintains: Neutral | $24 → $21 | $18.89 | +11.17% | 7 | Oct 31, 2025 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $585 → $600 | $569.71 | +5.32% | 3 | Oct 23, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $135 → $140 | $98.57 | +42.03% | 14 | Oct 23, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $190 → $214 | $205.33 | +4.22% | 6 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $230 → $89 | $134.75 | -33.95% | 7 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $8 | $11.86 | -32.55% | 4 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $57 | $29.28 | +94.67% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $19.93 | -14.70% | 15 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $134 | $107.46 | +24.70% | 2 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $36.27 | +59.91% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $5 | $8.56 | -41.59% | 2 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $125.29 | +18.13% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $365.95 | +1.11% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $75 | $83.98 | -10.69% | 12 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $2.97 | -24.24% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $4.31 | +19,041.53% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $28.33 | -50.58% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $59.77 | +67.31% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $16.66 | -27.97% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $30 | $33.18 | -9.58% | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $37.39 | +20.35% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $193.57 | +42.07% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $4.99 | +300.80% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $6.89 | +509.58% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $60 | $6.40 | +837.50% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.73 | +1,954.79% | 1 | Sep 1, 2020 |
Medtronic
Nov 19, 2025
Maintains: Neutral
Price Target: $95 → $102
Current: $101.97
Upside: +0.03%
Insulet
Nov 19, 2025
Upgrades: Buy
Price Target: $355 → $400
Current: $307.56
Upside: +30.06%
Treace Medical Concepts
Nov 7, 2025
Maintains: Neutral
Price Target: $6.5 → $5.85
Current: $2.68
Upside: +118.28%
Zimmer Biomet Holdings
Nov 6, 2025
Maintains: Sell
Price Target: $96 → $88
Current: $93.10
Upside: -5.48%
InMode
Nov 6, 2025
Maintains: Neutral
Price Target: $16 → $16
Current: $14.44
Upside: +10.80%
DexCom
Nov 3, 2025
Maintains: Buy
Price Target: $106 → $95
Current: $64.85
Upside: +46.49%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $24 → $21
Current: $18.89
Upside: +11.17%
Intuitive Surgical
Oct 23, 2025
Maintains: Neutral
Price Target: $585 → $600
Current: $569.71
Upside: +5.32%
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $135 → $140
Current: $98.57
Upside: +42.03%
Johnson & Johnson
Oct 14, 2025
Maintains: Buy
Price Target: $190 → $214
Current: $205.33
Upside: +4.22%
Sep 22, 2025
Downgrades: Neutral
Price Target: $230 → $89
Current: $134.75
Upside: -33.95%
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $11.86
Upside: -32.55%
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $29.28
Upside: +94.67%
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $19.93
Upside: -14.70%
Jul 31, 2025
Maintains: Buy
Price Target: $125 → $134
Current: $107.46
Upside: +24.70%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $36.27
Upside: +59.91%
Jan 27, 2025
Maintains: Buy
Price Target: $5.5 → $5
Current: $8.56
Upside: -41.59%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $125.29
Upside: +18.13%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $365.95
Upside: +1.11%
Sep 10, 2024
Maintains: Neutral
Price Target: $90 → $75
Current: $83.98
Upside: -10.69%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $2.97
Upside: -24.24%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $4.31
Upside: +19,041.53%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $28.33
Upside: -50.58%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $59.77
Upside: +67.31%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $16.66
Upside: -27.97%
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $33.18
Upside: -9.58%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $37.39
Upside: +20.35%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $193.57
Upside: +42.07%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $4.99
Upside: +300.80%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $6.89
Upside: +509.58%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $60
Current: $6.40
Upside: +837.50%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.73
Upside: +1,954.79%